Chinese english Germany Japanese Korea

OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID)

OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Struktur
82419-52-1
CAS-Nr.
82419-52-1
Englisch Name:
OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID)
Synonyma:
Ofloxacin-3;Desmethyl Ofloxacin;Ofloxacin EP IMpurity E;Ofloxacin impurity E CRS;Ofloxacin Impurity 5（HCl）;Ofloxacin Related CoMpound A;Ofloxacin USP Related Compound A;Desmethyl Ofloxacin Hydrochloride;Ofloxacin EP Impurity E (USP RC A);(RS)-9-Fluoro-3-methyl-7-oxo-10-(pi
CBNumber:
CB7500554
Summenformel:
C17H18FN3O4
Molgewicht:
347.34
MOL-Datei:
82419-52-1.mol
Request For Quotation

OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Eigenschaften

Schmelzpunkt:
>2500C (dec.)
Siedepunkt:
600.7±55.0 °C(Predicted)
Dichte
1.51±0.1 g/cm3(Predicted)
storage temp. 
-20°C Freezer
Löslichkeit
Aqueous Base (Slightly), DMSO (Slightly, Heated, Sonicated), Methanol (Slightly)
pka
5.19±0.40(Predicted)
Farbe
Pale Yellow
BRN 
4890029
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn
R-Sätze: 22
HS Code  2934990002
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
Sicherheit

OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Pale Yellow Solid

Verwenden

A metabolite of Ofloxacin

OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 83)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14336 58
Shaanxi Dideu Medichem Co. Ltd 		18192627656
 1012@dideu.com China 3320 58
Dideu Industries Group Limited 		+86-29-89586680 +86-15129568250
 1026@dideu.com China 29067 58
Hangzhou Huarong Pharm Co., Ltd. 		571-86758373 +8613588754946
 sales@huarongpharm.com CHINA 3149 58
sgtlifesciences pvt ltd 		+8617013299288
 dj@sgtlifesciences.com China 12382 58
LEAP CHEM CO., LTD. 		+86-852-30606658
market18@leapchem.com China 24738 58
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49739 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Amadis Chemical Company Limited 		571-89925085
sales@amadischem.com China 131981 58
ROSEWA HOLDING GROUP CO.,LIMITED 		+86-023-62871537
sales@rosewachem.com China 2830 58
  • OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID)
  • 9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
  • Desmethyl Ofloxacin
  • 9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Hydrochloride
  • Desmethyl Ofloxacin Hydrochloride
  • (RS)-9-fluoro-2,3-dihydro-3-Methyl-7-oxo-10-(piperazin-1-yl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
  • Ofloxacin Related CoMpound A
  • Ofloxacin Related Compound A (25 mg) ((RS)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(piperazin-1-yl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
  • Ofloxacin EP IMpurity E
  • 9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
  • Ofloxacin Related Compound A (25 mg) (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
  • Ofloxacin-3
  • Ofloxacin EP Impurity E (USP RC A)
  • (RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid HCl
  • Ofloxacin Impurity 5(Ofloxacin EP Impurity E)
  • 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
  • (RS)-9-Fluoro-3-methyl-7-oxo-10-(pi
  • Ofloxacin impurity E CRS
  • 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-
  • Ofloxacin Impurity 5（HCl）
  • Ofloxacin Related Compound A (25 mg)
  • OFLOXACIN RELATED COMPOUND A USP/EP/BP
  • OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) USP/EP/BP
  • (R)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
  • Desmethyl Ofloxacin (Ofloxacin EP Impurity E)
  • Ofloxacin EP Impurity E (Desmethyl Ofloxacin)
  • Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2 (1478119)
  • Ofloxacin USP Related Compound A
  • Ofloxacin EP Impurity E (Ofloxacin USP Related Compound A)
  • 82419-52-1
  • C17H19ClFN3O4
  • Intermediates & Fine Chemicals
  • Various Metabolites and Impurities
  • Metabolites & Impurities
  • Pharmaceuticals
Copyright 2019 © ChemicalBook. All rights reserved